SolitonReach
PrivateLast Round
Debt
Jul 1, 2023
Total Funding Raised
$4.65M
Company Overview
SolitonReach is a medical devices company that has developed a medical rehabilitation motion capture system with small, lightweight, wireless sensors that can be worn on the body.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Vertical SaaS, CRM, Telemedicine, Revenue Cycle
Business Model
B2B
Customer Profile
Subscription SaaS, Payment Processing Fee, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SolitonReach Comparables
Compare SolitonReach with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Luma Health | 90% | |
| DoctorConnect | 88% | |
| NexHealth | 87% | |
SolitonReach Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jul 1, 2023 | ||||
| Seed | Jan 16, 2020 | ||||
| Growth Equity | May 10, 2012 |
SolitonReach Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Proton Enterprises | Seed |
| Summit Partners | Growth Equity |
| Monte Carlo Capital | Seed |
SolitonReach Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SolitonReach's valuation, stock price, and market status.